Skip to content
  • About Prolight
    • Market
    • Partnerships
    • Board of Directors and Management
    • History
    • Cutting-edge technology
    • Vision & strategy
  • Products
    • Psyros™
    • MicroFlex
    • Patents
  • Investors
    • Press releases
    • Financial reports
    • CEO comment
    • Financial calendar
    • Stock information
    • AGM
    • Shareholders
    • Key figures
    • Corporate governance
    • Prospectus
  • Media
    • Press releases
    • Investor letters
    • Media gallery
    • Presentations
    • Articles
    • Native ads
  • Contact us
Menu
  • About Prolight
    • Market
    • Partnerships
    • Board of Directors and Management
    • History
    • Cutting-edge technology
    • Vision & strategy
  • Products
    • Psyros™
    • MicroFlex
    • Patents
  • Investors
    • Press releases
    • Financial reports
    • CEO comment
    • Financial calendar
    • Stock information
    • AGM
    • Shareholders
    • Key figures
    • Corporate governance
    • Prospectus
  • Media
    • Press releases
    • Investor letters
    • Media gallery
    • Presentations
    • Articles
    • Native ads
  • Contact us
  • EN
  • SV

Native ads

2022 (only in Swedish)

  • Svenska Prolight Diagnostics kan bli ett helt unikt bolag inom patientnära testsystem – DN Innovation
  • Prolight Diagnostics kan bli ett unikt bolag inom patientnära testsystem, IR-intervju -Dagens industri
  • Prolight Diagnostics förvärvar brittiskt bolag för att ta en ledande position inom patientnära diagnostik -BioStock
  • Banbrytande testsystem kan revolutionera klinisk diagnostisering -Affärsvärlden
  • Kan vara början på ett paradigmskifte inom POC -Aktiespararna
  • Prolight Diagnostics kan bli ett helt unikt bolag inom patientnära testsystem – Realtid
  • About Prolight
  • Products
  • Investors
  • Media
  • Contact us
  • About Prolight
  • Products
  • Investors
  • Media
  • Contact us

Subscribe